Cargando…
Naptumomab Estafenatox: Targeted Immunotherapy with a Novel Immunotoxin
Improvement of cancer therapy by introducing new concepts is still urgent even though there have been major advancements lately. Immunotherapy is well on the way to becoming an established tool in the cancer treatment armory. It seems that a combination of (1) activation of immune effector cells and...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918406/ https://www.ncbi.nlm.nih.gov/pubmed/24445502 http://dx.doi.org/10.1007/s11912-013-0370-0 |